Skip to main content

Table 2 Laboratory data at diagnosis

From: Clinical analysis of chronic active EBV infection with coronary artery dilatation and a matched case–control study

Pt

WBC (× 109/L)

Hb (g/L)

PLT (× 109/L)

ALT (U/L)

AST (U/L)

CK-MB (U/L)

EBV-DNA (whole blood) (Copies/mL)

EBV-DNA (plasma) (Copies/mL)

sCD25 (ng/L)

SF (ug/L)

IL-6 (ng/L)

IL-10 (ng/L)

TNF-α (ng/L)

1

2.45

108

144

1928.0

1806.0

24

1.56 × 107

5.00 × 103

1830.0

216.0

13.95

7.06

6.57

2

6.01

121

137

524.0

584.1

20

1.60 × 107

2.94 × 104

8922.0

296.8

14.53

6.03

1.16

3

1.49

73

56

240.2

108.0

32

6.37 × 106

6.75 × 103

4574.0

89.3

12.45

10.15

2.59

4

6.41

122

422

68.9

141.6

22

7.70 × 106

2.08 × 103

1504.0

108.6

143.85

2.60

113.62

5

2.57

102

201

464.8

331.8

32

3.50 × 105

3.17 × 103

2541.0

509.4

11.77

3.23

0.00

6

7.87

98

118

221.2

368.5

14

1.15 × 107

3.77 × 105

23,684.0

888.0

19.44

18.00

3.60

7

5.19

111

137

38.4

26.2

19

1.9 × 105

1.30 × 105

3847.6

64.7

2500.00

1.79

525.62

8

9.91

131

270

22.8

12.2

10

3.96 × 107

1.54 × 103

3849.2

27.8

6.46

3.22

0.31

9

4.52

94

110

37.1

29.4

18

1.20 × 107

5.17 × 104

2987.0

67.5

4.98

4.25

2.73

10

4.87

104

30

876.0

103.4

33

1.44 × 107

1.76 × 106

8519.0

91,893.2

76.98

270.01

0.71

  1. Pt patient, WBC white blood cell, Hb hemoglobin, PLT platelet, ALT alanine transaminase, AST aspartate transaminase, CK-MB creatine kinase MB, EBV Epstein–Barr virus, CA capsid antigen, EA early antigen, NA nuclear antigen